MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Features of the quality of life and related disorders in patients with focal dystonia

Z.A. Akbarkhodjaeva, G.S. Rakhimbaeva (Tashkent, Uzbekistan)

Meeting: 2016 International Congress

Abstract Number: 1688

Keywords: Blepharospasm, Dystonia: Clinical features, Torticollis

Session Information

Date: Thursday, June 23, 2016

Session Title: Dystonia

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the features of the quality of life (QOL) and related disorders in patients with focal dystonia (FD).

Background: Studying neuropsychological disorders is important for assessing their impact on course of FD, patients QOL, understanding of common etiological and pathogenic mechanisms, choosing most effective approaches to treatment.

Methods: 38 patients (25-66 years) with focal dystonia (blepharospasm n = 22, spasmodic torticollis n = 16) were observed during two years. We used questionnaires for assessment fatigue, insomnia, QOL, neuropsychological methods for determining level of anxiety and depression. All patients received Botulinum toxin (BT) 3-4 times a year and underwent examinations before therapy with BT and after one month (achieving maximum effect).

Results: Half of patients with blepharospasm diagnosed chronic tension headache (TH). Muscle spasms, muscle hypertonicity followed by significantly pronounced muscular-tonic syndrome, TH in majority of patients with spastic torticollis. Nowadays it is believed that pain afferentation supports and enhances neurotransmitter imbalances, contributing development of extrapyramidal disorders. In 2/3 of the cases evaluated polialgic syndrome. Pain, significantly affects emotional background of patients (79,3%- high level of anxiety, depression), sleep quality (65.8%), followed by, hampered daily activities, affects QOL, which was reduced in all patients. According to QOL questionnaire, dissatisfaction from current life situation was noted in 93.6% of patients, decrease of self-concept -61,7%, anxiety about the future – at 57.7%, decrease in social contact – at 59.7%. Severity of comorbidities was significantly higher before BT therapy and decreased against the reducing clinical manifestations of dystonic disorders month after BT therapy. It was found that psychosomatic disorders has negative influence on the effectiveness duration of BT. Dynamic observation showed that prescription of antidepressants to patients with high levels of anxiety, depression not only reduces emotional disorders and associated insomnia, improves QOL, but also contributes to lengthening positive clinical effect of BT.

Conclusions: Algic and comorbid psychosomatic disorders are frequently observed in FD, adversely affects the course of the underlying disease, QOL, reduces duration of BT effect, requires consideration in the planning of rehabilitation measures.

To cite this abstract in AMA style:

Z.A. Akbarkhodjaeva, G.S. Rakhimbaeva. Features of the quality of life and related disorders in patients with focal dystonia [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/features-of-the-quality-of-life-and-related-disorders-in-patients-with-focal-dystonia/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/features-of-the-quality-of-life-and-related-disorders-in-patients-with-focal-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley